Conor Killmurray


Pembrolizumab Potentially Most Effective Before Surgery in High-Risk Melanoma

September 18, 2022

The rate of event-free survival associated with pembrolizumab was significantly higher among patients with high-risk melanoma about to undergo surgery than among those who received immunotherapy following surgery.

Managing GI AEs in Metastatic Breast Cancer

December 15, 2020

Gastrointestinal (GI) adverse events (AEs) that occurred in patients with metastatic breast cancer who were treated with oral paclitaxel and encequidar can be managed by the use of 5- HT3 inhibitors and early intervention with loperamide, according to research presented at the 2020 San Antonio Breast Cancer Symposium.

Essential Visits or Telemedicine During COVID-19: Expert Offers Advice

July 28, 2020

As COVID-19 cases continued to increase across the United States at the onset of the pandemic, many elective treatments and routine visits to hospitals and clinics were canceled or moved online. For patients with cancer, this has led to a transition to telehealth to make up for canceled visits. But not all visits can be conducted over a video call, mainly, cancer screenings.

Smoking Cessation Before a Lung Cancer Diagnosis Improves Outcomes

May 17, 2020

People who quit smoking at any time, even up to 2 years before a lung cancer diagnosis, have increased chances of survival after their diagnosis, according to data during a 2020 ASCO Virtual Scientific Program press briefing.